185 related articles for article (PubMed ID: 14651407)
1. Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney.
Day C; White B; Ross J; Dolan K
Aust N Z J Public Health; 2003 Oct; 27(5):558. PubMed ID: 14651407
[No Abstract] [Full Text] [Related]
2. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B vaccination and injecting drug users.
Budd J; Robertson R; Elton R
Br J Gen Pract; 2004 Jun; 54(503):444-7. PubMed ID: 15186567
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccination and injecting drug use: narrowing the efficacy-effectiveness gap.
Maher L
Int J Drug Policy; 2008 Dec; 19(6):425-8. PubMed ID: 18289840
[No Abstract] [Full Text] [Related]
6. Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia.
Rhodes T; Zikic B; Prodanović A; Kuneski E; Bernays S
Soc Sci Med; 2008 Mar; 66(6):1437-47. PubMed ID: 18201809
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
[TBL] [Abstract][Full Text] [Related]
8. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis vaccination among drug users.
Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A
Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B and C risk factors in Germany--results of the national surveillance].
Walter J; Radun D; Claus H; Hamouda O; Stark K
Gesundheitswesen; 2005 Jul; 67(7):441-7. PubMed ID: 16103966
[TBL] [Abstract][Full Text] [Related]
11. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
[TBL] [Abstract][Full Text] [Related]
12. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
Ellard J
Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
Baklan Z; Gorisek JR; Poljak M; Pisec A
Wien Klin Wochenschr; 2004; 116 Suppl 2():5-7. PubMed ID: 15506302
[TBL] [Abstract][Full Text] [Related]
14. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
15. Validity of injecting drug users' self report of hepatitis A, B, and C.
Schlicting EG; Johnson ME; Brems C; Wells RS; Fisher DG; Reynolds G
Clin Lab Sci; 2003; 16(2):99-106. PubMed ID: 12757189
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B immunity in a population of drug and alcohol users.
Polizzotto MN; Whelan G
Drug Alcohol Rev; 2007 Jul; 26(4):417-9. PubMed ID: 17564878
[TBL] [Abstract][Full Text] [Related]
17. [Knowledge about hepatitis B and C viruses and HIV among blood donors in Casablanca].
Boutayeb H; Aamoum A; Benchemsi N
East Mediterr Health J; 2006 Sep; 12(5):538-47. PubMed ID: 17333791
[TBL] [Abstract][Full Text] [Related]
18. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
[TBL] [Abstract][Full Text] [Related]
19. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
20. 'It's your life!': injecting drug users, individual responsibility and hepatitis C prevention.
Fraser S
Health (London); 2004 Apr; 8(2):199-221. PubMed ID: 15068637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
